The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 02, 2016

Filed:

Aug. 19, 2013
Applicant:

Physio-control, Inc., Redmond, WA (US);

Inventors:

Tae H. Joo, Redmond, WA (US);

Ronald E. Stickney, Edmonds, WA (US);

Cynthia P. Jayne, Redmond, WA (US);

Paula Lank, Renton, WA (US);

Patricia O'Hearn, Mercer Island, WA (US);

David R. Hampton, Woodinville, WA (US);

James W. Taylor, Sammamish, WA (US);

William E. Crone, Fall City, WA (US);

Daniel Yerkovich, Seattle, WA (US);

Assignee:

PHYSIO-CONTROL, INC., Redmond, WA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61N 1/39 (2006.01); A61M 16/00 (2006.01); A61B 7/00 (2006.01); A61B 7/04 (2006.01); A61B 5/053 (2006.01); A61B 5/00 (2006.01); A61B 5/0464 (2006.01); A61B 5/08 (2006.01); A61N 1/365 (2006.01);
U.S. Cl.
CPC ...
A61N 1/3987 (2013.01); A61B 5/0535 (2013.01); A61B 7/00 (2013.01); A61B 7/04 (2013.01); A61M 16/00 (2013.01); A61N 1/39 (2013.01); A61N 1/3925 (2013.01); A61B 5/0464 (2013.01); A61B 5/0809 (2013.01); A61B 5/7264 (2013.01); A61N 1/36578 (2013.01);
Abstract

A cardiac pulse in a patient is determined by evaluating physiological signals in the patient. A medical device evaluates two or more different physiological signals, such as phonocardiogram (PCG) signals, electrocardiogram (ECG) signals, patient impedance signals, piezoelectric signals, and accelerometer signals for features indicative of the presence of a cardiac pulse. Using these features, the medical device determines whether a cardiac pulse is present in the patient. The medical device may also be configured to report whether the patient is in a VF, VT, asystole, or PEA condition, in addition to being in a pulseless condition, and prompt different therapies, such as chest compressions, rescue breathing, defibrillation, and PEA-specific electrotherapy, depending on the analysis of the physiological signals. Auto-capture of a cardiac pulse using pacing stimuli is further provided. The medical devices, or any portion thereof, can be worn by the patient or may be attached to the patient.


Find Patent Forward Citations

Loading…